Nova Life

GCC Healthcare Investment Trends in 2026

An overview of where institutional and family-office capital is flowing in GCC healthcare in 2026, with implications for operators planning expansion, fund-raising, or exit.

Platform plays

Single-specialty roll-ups in dental, dermatology, IVF, and ophthalmology continue to attract regional private equity, with valuations rewarding clinical standardisation and multi-site operating discipline.

Day surgery & oncology

Day surgery centres and outpatient oncology are emerging as the next institutional asset classes as payers shift volume out of inpatient hospitals.

Digital health

Care navigation, RCM platforms, and chronic disease tech are attracting cross-border capital, especially where founders have proven UAE or KSA payer integrations.

Contact Nova Life

Speak with a Nova Life advisor about clinic setup, licensing, M&A, or operations in the UAE.